EZH2 and gastric cancer: The results revealed that the knockdown of EZH2 significantly inhibited the proliferation and invasion of the SGC7901 cells, which resembled the suppressive effects of miR-217 overexpression in gastric cancer cells (Figure 6C and 6D).